Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
Protein arginine methyltransferase (PRMT) 5 is over-expressed in a variety of cancers and the master transcription regulator E2F1 is an important methylation target. We have explored the role of PRMT5 and E2F1 in regulating the non-coding genome and report here a striking effect on long non-coding (...
主要な著者: | Barczak, W, Carr, SM, Liu, G, Munro, S, Nicastri, A, Lee, LN, Hutchings, C, Ternette, N, Klenerman, P, Kanapin, A, Samsonova, A, La Thangue, NB |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Nature
2023
|
類似資料
-
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
著者:: Wojciech Barczak, 等
出版事項: (2023-02-01) -
Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control
著者:: Roworth, A, 等
出版事項: (2019) -
Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma
著者:: Bate‐Eya, LT, 等
出版事項: (2024) -
Lysine methylation regulates the pRb tumour suppressor protein.
著者:: Munro, S, 等
出版事項: (2010) -
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
著者:: Liu, G, 等
出版事項: (2023)